this protocol is based upon one developed in sugimura 's laboratory with modifications , including the use of flavin mononucleotide ( fmn ) rather than riboflavin to reduce the azo compounds to free amines , and hamster liver s9 rather then rat liver s9 for metabolic activation .
C0016388
fmn
C0035527
riboflavin